(Q70832473)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

125I-Clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

R B Moss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

Y P Hsu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

N J Lewiston

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

language of work or name

English

0 references

publication date

1 August 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

14 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

215-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

Cystic fibrosis. An expanding challenge for internal medicine

14 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

The tracheobronchial submucosal glands in cystic fibrosis: A qualitative and quantitative histochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Bronchial mucus in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Opsonic defect in patients with cystic fibrosis of the pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Bronchial hyperreactivity in cystic fibrosis and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Circulating immune complexes in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

7 January 2021

Immunologic Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Microtiter solid-phase radioimmunoassay for specific immunoglobulin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Human Immunity to Pseudomonas aeruginosa. II. Relationship between Heat-Stable Opsonins and Type-Specific Lipopolysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Hypogammaglobulinemia in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Pseudomonas colonization in cystic fibrosis. A study of 160 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Carbenicillin in patients with cystic fibrosis:Clinical pharmacology and therapeutic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Pseudomonas aeruginosa infections: persisting problems and current research to find new therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Genetics of human immune response to allergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Staphylococcal IgE Antibodies, Hyperimmunoglobulinemia E andStaphylococcus aureusInfections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Immune Complexes in Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Episodic arthritis in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Cutaneous necrotizing venulitis in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

Immediate hypersensitivity in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Immune Complex Disease in Experimental Animals and Man

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2881%2980453-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(81)80453-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7252678%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference